What is Glow?
Founded by technology veterans including Max Levchin, Glow operates at the intersection of data science and reproductive health. The company has developed a robust ecosystem of applications, including the flagship Glow app, Glow Nurture, and Eve by Glow, which collectively serve as a repository for critical health metrics. By utilizing proprietary algorithms, Glow aims to transform how individuals manage their reproductive health while simultaneously contributing to large-scale scientific research. The firm's market position is defined by its ability to synthesize user-generated health data into actionable insights, effectively bridging the gap between personal wellness tracking and clinical-grade data analysis.
How much funding has Glow raised?
Glow has raised a total of $23M across 2 funding rounds:
Series A
$6M
Series B
$17M
Series A (2013): $6M with participation from Andreessen Horowitz and Founders Fund
Series B (2014): $17M led by Founders Fund, Andreessen Horowitz, and Formation8
Key Investors in Glow
Founders Fund
A venture capital firm that invests in high-impact companies across all sectors, known for its founder-friendly approach and history of backing transformative technology firms.
Andreessen Horowitz
A premier venture capital firm that provides strategic support and capital to entrepreneurs building the next generation of technology companies.
Formation8
A venture capital firm specializing in supporting entrepreneurs who are building market-leading smart enterprise and energy technology companies with global scale.
What's next for Glow?
With the infusion of capital from its latest financing rounds, Glow is positioned to scale its enterprise-level operations and deepen its research capabilities. The strategic focus will likely shift toward expanding its data infrastructure to support more sophisticated predictive modeling in reproductive health. As the company matures, it is expected to leverage its existing user base to foster partnerships with medical institutions and research organizations, potentially setting new standards for data-driven health outcomes. The firm's ability to maintain its growth trajectory will depend on its continued success in navigating the complex regulatory landscape of health data while scaling its technological footprint globally.
See full Glow company page
